HOUSTON--(BUSINESS WIRE)--Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM), a clinical stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies, today reported financial results for the first quarter of 2015, and provided an update on the Company’s recent developments.
Help employers find you! Check out all the jobs and post your resume.
